142 related articles for article (PubMed ID: 25559742)
21. Identification of potent orally active factor Xa inhibitors based on conjugation strategy and application of predictable fragment recommender system.
Ishihara T; Koga Y; Iwatsuki Y; Hirayama F
Bioorg Med Chem; 2015 Jan; 23(2):277-89. PubMed ID: 25523211
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and structure-activity relationships of novel selective factor Xa inhibitors with a tetrahydroisoquinoline ring.
Ueno H; Yokota K; Hoshi J; Yasue K; Hayashi M; Hase Y; Uchida I; Aisaka K; Katoh S; Cho H
J Med Chem; 2005 May; 48(10):3586-604. PubMed ID: 15887966
[TBL] [Abstract][Full Text] [Related]
23. Design of highly potent noncovalent thrombin inhibitors that utilize a novel lipophilic binding pocket in the thrombin active site.
Tucker TJ; Lumma WC; Mulichak AM; Chen Z; Naylor-Olsen AM; Lewis SD; Lucas R; Freidinger RM; Kuo LC
J Med Chem; 1997 Mar; 40(6):830-2. PubMed ID: 9083470
[No Abstract] [Full Text] [Related]
24. A new peptide (Ruviprase) purified from the venom of Daboia russelii russelii shows potent anticoagulant activity via non-enzymatic inhibition of thrombin and factor Xa.
Thakur R; Kumar A; Bose B; Panda D; Saikia D; Chattopadhyay P; Mukherjee AK
Biochimie; 2014 Oct; 105():149-58. PubMed ID: 25038567
[TBL] [Abstract][Full Text] [Related]
25. Assessing the Role of a Malonamide Linker in the Design of Potent Dual Inhibitors of Factor Xa and Cholinesterases.
Purgatorio R; Gambacorta N; Samarelli F; Lopopolo G; de Candia M; Catto M; Nicolotti O; Altomare CD
Molecules; 2022 Jul; 27(13):. PubMed ID: 35807514
[TBL] [Abstract][Full Text] [Related]
26. Novel strategy to boost oral anticoagulant activity of blood coagulation enzyme inhibitors based on biotransformation into hydrophilic conjugates.
Ishihara T; Koga Y; Mori K; Sugasawa K; Iwatsuki Y; Hirayama F
Bioorg Med Chem; 2014 Nov; 22(22):6324-32. PubMed ID: 25438755
[TBL] [Abstract][Full Text] [Related]
27. Crystal structures of factor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of factor Xa and selectivity against thrombin.
Stubbs MT; Huber R; Bode W
FEBS Lett; 1995 Nov; 375(1-2):103-7. PubMed ID: 7498454
[TBL] [Abstract][Full Text] [Related]
28. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and biological activity of novel purine and bicyclic pyrimidine factor Xa inhibitors.
Buckman BO; Mohan R; Koovakkat S; Liang A; Trinh L; Morrissey MM
Bioorg Med Chem Lett; 1998 Aug; 8(16):2235-40. PubMed ID: 9873520
[TBL] [Abstract][Full Text] [Related]
30. Rational design, synthesis, and biological activity of benzoxazinones as novel factor Xa inhibitors.
Dudley DA; Bunker AM; Chi L; Cody WL; Holland DR; Ignasiak DP; Janiczek-Dolphin N; McClanahan TB; Mertz TE; Narasimhan LS; Rapundalo ST; Trautschold JA; Van Huis CA; Edmunds JJ
J Med Chem; 2000 Nov; 43(22):4063-70. PubMed ID: 11063603
[TBL] [Abstract][Full Text] [Related]
31. A novel factor Xa inhibitor: structure-activity relationships and selectivity between factor Xa and thrombin.
Katakura S; Nagahara T; Hara T; Iwamoto M
Biochem Biophys Res Commun; 1993 Dec; 197(2):965-72. PubMed ID: 8267636
[TBL] [Abstract][Full Text] [Related]
32. Orally bioavailable factor Xa inhibitors containing alpha-substituted gem-dimethyl P4 moieties.
Orwat MJ; Qiao JX; He K; Rendina AR; Luettgen JM; Rossi KA; Xin B; Knabb RM; Wexler RR; Lam PY; Pinto DJ
Bioorg Med Chem Lett; 2014 Aug; 24(15):3341-5. PubMed ID: 24951330
[TBL] [Abstract][Full Text] [Related]
33. From natural products to achiral drug prototypes: potent thrombin inhibitors based on P2/P3 dihydropyrid-2-one core motifs.
Hanessian S; Therrien E; Zhang J; Otterlo Wv; Xue Y; Gustafsson D; Nilsson I; Fjellström O
Bioorg Med Chem Lett; 2009 Sep; 19(18):5429-32. PubMed ID: 19674897
[TBL] [Abstract][Full Text] [Related]
34. Comparative binding energy analysis considering multiple receptors: a step toward 3D-QSAR models for multiple targets.
Murcia M; Morreale A; Ortiz AR
J Med Chem; 2006 Oct; 49(21):6241-53. PubMed ID: 17034130
[TBL] [Abstract][Full Text] [Related]
35. 1,2-Dibenzamidobenzene inhibitors of human factor Xa.
Herron DK; Goodson T; Wiley MR; Weir LC; Kyle JA; Yee YK; Tebbe AL; Tinsley JM; Mendel D; Masters JJ; Franciskovich JB; Sawyer JS; Beight DW; Ratz AM; Milot G; Hall SE; Klimkowski VJ; Wikel JH; Eastwood BJ; Towner RD; Gifford-Moore DS; Craft TJ; Smith GF
J Med Chem; 2000 Mar; 43(5):859-72. PubMed ID: 10715153
[TBL] [Abstract][Full Text] [Related]
36. Crystal structures of human factor Xa complexed with potent inhibitors.
Maignan S; Guilloteau JP; Pouzieux S; Choi-Sledeski YM; Becker MR; Klein SI; Ewing WR; Pauls HW; Spada AP; Mikol V
J Med Chem; 2000 Aug; 43(17):3226-32. PubMed ID: 10966741
[TBL] [Abstract][Full Text] [Related]
37. Microfluidic Chip-Based Online Screening Coupled to Mass Spectrometry: Identification of Inhibitors of Thrombin and Factor Xa.
Iyer JK; Otvos RA; Kool J; Kini RM
J Biomol Screen; 2016 Feb; 21(2):212-20. PubMed ID: 26323281
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position.
Tucker TJ; Brady SF; Lumma WC; Lewis SD; Gardell SJ; Naylor-Olsen AM; Yan Y; Sisko JT; Stauffer KJ; Lucas BJ; Lynch JJ; Cook JJ; Stranieri MT; Holahan MA; Lyle EA; Baskin EP; Chen IW; Dancheck KB; Krueger JA; Cooper CM; Vacca JP
J Med Chem; 1998 Aug; 41(17):3210-9. PubMed ID: 9703466
[TBL] [Abstract][Full Text] [Related]
39. [New antithrombotic oligosaccharides].
Petitou M; Hérault JP; Bernat A; Driguez PA; Duchaussoy P; Lormeau JC; Herbert JM
Ann Pharm Fr; 1999 May; 57(3):232-9. PubMed ID: 10427858
[TBL] [Abstract][Full Text] [Related]
40. Similarity study of serine proteases inhibitors.
Perekhodtsev GD
Mol Divers; 2006 Feb; 10(1):81-3. PubMed ID: 16404529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
